Furthermore, higher FGF21 level was detected in different metabolic disorders, including type 2 diabetes (55), obesity and liver steatosis (56, 57), pancreatitis (58), and primary mitochondrial dysfunction (59). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.